Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 2204

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 12
Chunk 2204
---
 Knuettel directly and all
    other stock options are held of record by Camden. Mr. Knuettel serves as Managing Member of Camden and co-trustee, with individual
    dispositive power of the Lara Knuettel Revocable Trust, and accordingly, may be deemed to beneficially own the shares of Common
    Stock owned directly by Camden and the Lara Knuettel Revocable Trust. 

    (3)
    For Mr. Friedberg,
    includes 15,000 shares of Common Stock issuable upon the exercise stock options held by Mr. Friedberg, which are exercisable
    for shares of Common Stock at a price of $22.68 per share, a RSU for 31,934 shares and 520,711 shares of Common Stock owned
    by Balmoral Financial Group LLC (“Balmoral”). In addition, Mr. Friedberg serves as a manager with individual dispositive
    power of Balmoral, and accordingly, may be deemed to beneficially own the shares of Common Stock owned directly by Balmoral.

    (4)
    For Mr. Davis, includes
    20,001 shares of Common Stock issuable upon the exercise of stock options held by Mr. Davis, which are exercisable for shares
    of Common Stock at a price of $22.68 per share, 22,223 shares of Common Stock issuable upon the exercise of stock options
    held by Mr. Davis, which are exercisable for shares of Common Stock at a price of $22.68 per share, an RSU for 64,039 shares
    and an additional 29,167 shares of Common Stock issued in a private placement in full satisfaction of the Company’s
    obligations under the Director Note.

    (5)
    For Mr. Malamut,
    includes 15,000 shares of Common Stock issuable upon the exercise of stock options held by Mr. Malamut, which are exercisable
    for shares of Common Stock at a price of $22.68 per share and an RSU for 31,934 shares.

    (6)
    For Ms. Simmons,
    includes 13,333 shares of Common Stock issuable upon the exercise of stock options held by Ms. Simmons, which are exercisable
    for shares of Common Stock at a price of $22.68 per share and 33,750 shares of Common Stock issuable upon the exercise of
    stock options held by Ms.